Select a community
All Communities
Home > Community Treatment Reports > Amitriptyline-Perphenazine Treatment Report
What is Amitriptyline-Perphenazine?

The combination of amitriptyline, a tricyclic antidepressant, and perphenazine, an antipsychotic agent is used in the treatment of patients with moderate to severe anxiety and depression. Off label it is used for depression with psychotic features.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Other 1 0
Emotional lability 1 0
Depression 1 0

Mouse over the table for more information

Dosages

  10 mg-2 mg daily 6 x 10 mg-2 mg daily 3 x 25 mg-2 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Amitriptyline-Perphenazine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe
2 67% Side effects too severe: 67%
Other
1 33% Other: 33%

See all 3 patients who’ve stopped taking Amitriptyline-Perphenazine

Currently Taking Amitriptyline-Perphenazine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
1
0
1

Stopped Taking Amitriptyline-Perphenazine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
1
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
0 0%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 24, 2009.